MEP48708A - Phosphonic acid compounds as inhibitors of serine proteases - Google Patents

Phosphonic acid compounds as inhibitors of serine proteases

Info

Publication number: MEP48708A
Authority: ME; Montenegro
Prior art keywords: phosphonic acid; acid compounds; inhibitors; serine proteases; serine protease
Prior art date: 2001-10-19

Application number

MEP-487/08A

Other languages

Bosnian (bs)

English (en)

Croatian (hr)

Inventor

Michael N Greco

Harold R Almond

Garavilla Lawrence De

Michael J Hawkins

Bruce E Maryanoff

Yun Qian

Donald Gilmore Walker

Sergio Cesco-Cancian

Christopher Norman Nilsen

Mitul N Patel

Michael J Humora

Original Assignee

Ortho Mcneil Janssen Pharm

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-19

Filing date

2002-10-17

Publication date

2011-02-10

2002-10-17 Application filed by Ortho Mcneil Janssen Pharm filed Critical Ortho Mcneil Janssen Pharm

2011-02-10 Publication of MEP48708A publication Critical patent/MEP48708A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3882—Arylalkanephosphonic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

MEP-487/08A 2001-10-19 2002-10-17 Phosphonic acid compounds as inhibitors of serine proteases MEP48708A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33034301P	2001-10-19	2001-10-19
PCT/US2002/033206 WO2003035654A1 (en)	2001-10-19	2002-10-17	Phosphonic acid compounds as inhibitors of serine proteases

Publications (1)

Publication Number	Publication Date
MEP48708A true MEP48708A (en)	2011-02-10

Family

ID=23289339

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-487/08A MEP48708A (en)	2001-10-19	2002-10-17	Phosphonic acid compounds as inhibitors of serine proteases

Country Status (27)

Country	Link
US (1)	US20030195172A1 (xx)
EP (1)	EP1438316B1 (xx)
JP (1)	JP4423033B2 (xx)
KR (2)	KR101011175B1 (xx)
CN (1)	CN100506831C (xx)
AR (1)	AR037245A1 (xx)
AT (1)	ATE330961T1 (xx)
AU (1)	AU2002356818C1 (xx)
BR (1)	BR0213961A (xx)
CA (1)	CA2464111C (xx)
CY (1)	CY1105166T1 (xx)
DE (1)	DE60212675T2 (xx)
DK (1)	DK1438316T3 (xx)
ES (1)	ES2266634T3 (xx)
HU (1)	HUP0600339A2 (xx)
IL (2)	IL161476A0 (xx)
ME (1)	MEP48708A (xx)
MX (1)	MXPA04003707A (xx)
MY (1)	MY133586A (xx)
NO (1)	NO20042057L (xx)
NZ (1)	NZ532372A (xx)
PL (1)	PL209032B1 (xx)
PT (1)	PT1438316E (xx)
RS (1)	RS50944B (xx)
RU (1)	RU2311421C2 (xx)
WO (1)	WO2003035654A1 (xx)
ZA (1)	ZA200403824B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7459461B2 (en)	2001-10-19	2008-12-02	Ortho-Mcneil Pharmaceutical, Inc.	Phosphonic acid compounds as inhibitors of serine proteases
US7601847B2 (en)	2004-10-26	2009-10-13	Wyeth	Preparation and purification of 4-(indazol-3-yl)phenols
JP5004590B2 (ja)	2004-12-02	2012-08-22	第一三共株式会社	７員環化合物並びにその製造法および医薬用途
CN101133046B (zh) *	2005-01-06	2011-08-03	先灵公司	酮酰胺的制备
WO2007084397A2 (en) *	2006-01-12	2007-07-26	Janssen Pharmaceutica N.V.	Processing of slpi by chymase
WO2007139230A1 (ja)	2006-05-31	2007-12-06	Asubio Pharma Co., Ltd.	７員環化合物並びにその製造法および医薬用途
UY31398A1 (es) *	2007-10-16	2009-04-30		Proceso para sintetizar compuestos de ácido fosfónico y posfínico
CN104488339A (zh)	2012-07-24	2015-04-01	富士通株式会社	无线终端、无线基站、无线通信系统以及无线通信方法
CN107353305A (zh) *	2017-07-12	2017-11-17	浙江普洛得邦制药有限公司	一种噁唑烷酮类抗菌药物的三羟甲基氨基甲烷盐及其晶型a、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5508273A (en) *	1993-12-30	1996-04-16	Ortho Pharmaceutical Corporation	Substituted phosphonic acids and derivatives useful in treating bone wasting diseases
DE69630701T2 (de) *	1995-07-17	2004-08-19	Cephalon, Inc.	Phosphor enthaltende hemmer von cystein- und serin-proteasen
DE19750002A1 (de) *	1997-11-12	1999-05-20	Solvay Pharm Gmbh	Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

2002
- 2002-10-17 KR KR1020047005810A patent/KR101011175B1/ko not_active Expired - Fee Related
- 2002-10-17 RS YUP-333/04A patent/RS50944B/sr unknown
- 2002-10-17 PL PL373860A patent/PL209032B1/pl not_active IP Right Cessation
- 2002-10-17 AU AU2002356818A patent/AU2002356818C1/en not_active Ceased
- 2002-10-17 DE DE60212675T patent/DE60212675T2/de not_active Expired - Lifetime
- 2002-10-17 PT PT02802153T patent/PT1438316E/pt unknown
- 2002-10-17 CN CNB028250982A patent/CN100506831C/zh not_active Expired - Fee Related
- 2002-10-17 CA CA2464111A patent/CA2464111C/en not_active Expired - Fee Related
- 2002-10-17 IL IL16147602A patent/IL161476A0/xx unknown
- 2002-10-17 ES ES02802153T patent/ES2266634T3/es not_active Expired - Lifetime
- 2002-10-17 MX MXPA04003707A patent/MXPA04003707A/es active IP Right Grant
- 2002-10-17 ME MEP-487/08A patent/MEP48708A/xx unknown
- 2002-10-17 HU HU0600339A patent/HUP0600339A2/hu unknown
- 2002-10-17 NZ NZ532372A patent/NZ532372A/en not_active IP Right Cessation
- 2002-10-17 RU RU2004111784/04A patent/RU2311421C2/ru not_active IP Right Cessation
- 2002-10-17 EP EP02802153A patent/EP1438316B1/en not_active Expired - Lifetime
- 2002-10-17 AT AT02802153T patent/ATE330961T1/de active
- 2002-10-17 DK DK02802153T patent/DK1438316T3/da active
- 2002-10-17 KR KR1020107011999A patent/KR20100074322A/ko not_active Withdrawn
- 2002-10-17 WO PCT/US2002/033206 patent/WO2003035654A1/en not_active Ceased
- 2002-10-17 JP JP2003538169A patent/JP4423033B2/ja not_active Expired - Fee Related
- 2002-10-17 BR BR0213961-8A patent/BR0213961A/pt not_active Application Discontinuation
- 2002-10-17 US US10/273,208 patent/US20030195172A1/en not_active Abandoned
- 2002-10-21 AR ARP020103969A patent/AR037245A1/es unknown
- 2002-10-21 MY MYPI20023912A patent/MY133586A/en unknown
2004
- 2004-04-18 IL IL161476A patent/IL161476A/en not_active IP Right Cessation
- 2004-05-18 ZA ZA200403824A patent/ZA200403824B/en unknown
- 2004-05-18 NO NO20042057A patent/NO20042057L/no not_active Application Discontinuation
2006
- 2006-08-23 CY CY20061101180T patent/CY1105166T1/el unknown

Also Published As

Publication number	Publication date
NO20042057L (no)	2004-05-18
NZ532372A (en)	2007-07-27
EP1438316A1 (en)	2004-07-21
CA2464111C (en)	2013-03-12
KR20100074322A (ko)	2010-07-01
MXPA04003707A (es)	2005-04-08
US20030195172A1 (en)	2003-10-16
ES2266634T3 (es)	2007-03-01
CA2464111A1 (en)	2003-05-01
WO2003035654A1 (en)	2003-05-01
JP2005537217A (ja)	2005-12-08
ATE330961T1 (de)	2006-07-15
CY1105166T1 (el)	2010-03-03
BR0213961A (pt)	2004-08-31
RU2004111784A (ru)	2005-10-20
CN1604904A (zh)	2005-04-06
PL209032B1 (pl)	2011-07-29
CN100506831C (zh)	2009-07-01
PL373860A1 (en)	2005-09-19
ZA200403824B (en)	2005-09-13
AR037245A1 (es)	2004-11-03
PT1438316E (pt)	2006-10-31
HK1065802A1 (en)	2005-03-04
IL161476A0 (en)	2004-09-27
IL161476A (en)	2009-09-01
DE60212675D1 (de)	2006-08-03
MY133586A (en)	2007-11-30
EP1438316B1 (en)	2006-06-21
KR20040060941A (ko)	2004-07-06
DK1438316T3 (da)	2006-10-16
RU2311421C2 (ru)	2007-11-27
HUP0600339A2 (en)	2006-08-28
JP4423033B2 (ja)	2010-03-03
KR101011175B1 (ko)	2011-01-26
AU2002356818C1 (en)	2009-10-22
DE60212675T2 (de)	2007-06-28
RS50944B (sr)	2010-08-31
RS33304A (sr)	2006-12-15
AU2002356818B2 (en)	2009-02-26

Publication	Publication Date	Title
EA200801530A1 (ru)	2008-12-30	Аналоги арилпропионамида, арилакриламида, арилпропинамида или арилметилмочевины в качестве фактор xia ингибиторов
NO990855D0 (no)	1999-02-23	Substituerte sykliske amin-metallprotease-inhibitorer
WO2006076575A3 (en)	2006-09-08	Substituted biaryl compounds as factor xia inhibitors
NO20070201L (no)	2007-03-12	Seksleddede heterocykler anvendelige som serinproteaseinhibitorer
AP1744A (en)	2007-05-29	Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
PT1383731E (pt)	2009-11-03	Compostos de biarilo como inibidores de serina-protease
NO20035603D0 (no)	2003-12-16	Fluorpyrrolidiner som dipeptidyl peptidase inhibitorer
ATE309264T1 (de)	2005-11-15	Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
EA200601358A1 (ru)	2007-02-27	Новые ингибиторы химазы
ATE335485T1 (de)	2006-09-15	Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
UY26154A1 (es)	2000-12-29	Aril y heteroaril piridonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación
DK0871454T3 (da)	2004-03-22	Phosphorholdige inhibitorer af cystein- og serinprotease
MEP48708A (en)	2011-02-10	Phosphonic acid compounds as inhibitors of serine proteases
UY26155A1 (es)	2000-12-29	Aril y heteroaril pirazinonas policiclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación.
MEP48608A (en)	2011-02-10	Piperazine containing phosphonic acid compounds as inhibitors of serine proteases
ATE289299T1 (de)	2005-03-15	Polyzyclisch aryl und heteroaryl substituierte 4- pyronen verwendbar als selektive hemmung von dem koagulationsprozess
ATE435201T1 (de)	2009-07-15	Neues mandelsäurederivat und seine verwendung als thrombininhibitor
TR199701483T1 (xx)	1998-03-21	�midazol(1,5a) Piridin T�revi Serin Proteaz �nhibit�rleri.
AR029855A1 (es)	2003-07-16	Formas de sal de un inhibidor de la proteasa del hiv
TW200612952A (en)	2006-05-01	Six-membered heterocycles useful as serine protease inhibitors